RAPPAPORT FAMILY INSTITUTE FOR RESEARCH IN THE MEDICAL SCIENCES
发明人:
申请号：
IL25355917
公开号：
IL253559D0
申请日:
2017.07.18
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
The present invention provides one kind for treating malignant tumour, including a effective amount of KPC1 of application, and peptide carries out at least about 70% and homologous to KPC1 or acts on behalf of which positive regulator of KPC1. In some embodiments, one kind is also provided for treating malignant tumour, and the p50 including applying therapeutically effective amount, peptide carries out at least about 70% and is equivalent to p50 or which positive modulators p50.
